Moon, Hyeong Cheol
Park, Sang Joon
Kim, Young Deok
Kim, Kyung Min
Kang, Ho
Lee, Eun Jung
Kim, Min-Sung
Kim, Jin Wook
Kim, Yong Hwy
Park, Chul-Kee
Kim, Young Gyu
Dho, Yun-Sik
Funding for this research was provided by:
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Korea Medical Device Development Fund granted by the Korean government (202012E08)
Article History
Received: 6 September 2021
Accepted: 7 March 2022
First Online: 16 March 2022
Competing interests
: Sang Joon Park is the founder and CEO of MEDICALIP. Chul-Kee Park and Yun-Sik Dho own stock options in MEDICALIP. Other authors have no conflict of interest to declare.